Market Overview:
The global facial injectable market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive procedures and rising awareness about aesthetic treatments. In terms of type, the hyaluronic acid segment is expected to lead the global facial injectable market during the forecast period. This can be attributed to its properties such as high viscosity, biocompatibility, and non-immunogenicity. In terms of application, hospitals are expected to lead the global facial injectable market during the forecast period owing to an increase in number of surgical procedures being performed in these settings.
Product Definition:
A facial injectable is a medication that is injected into the face to improve the appearance of wrinkles, lines, and other signs of aging. The importance of facial injectables is that they can help patients look younger without surgery.
Hyaluronic Acid:
Hyaluronic acid is a naturally occurring, non-toxic, highly viscous liquid that is found in the bodies of humans and animals. HA has multiple functions in the human body including lubrication of joints, maintenance of moisture levels in skin and mucous membranes as well as serving as a transport medium for vitamins, minerals and proteins.
Collagen:
Collagen is a protein that is found in the skin, tendons, bones and organs of all animals and humans. It helps to maintain the structure of skin, hair & nails as well as aids in wound healing process. The main functions of collagen are to strengthen & support facial tissues; it also provides resistance against aging effects and UV rays which leads to wrinkles.
Application Insights:
Based on application, the global facial injectable market is segmented into hospitals, clinics, research institutes and other sites. Hospitals were the largest revenue-generating centers in 2017 due to high usage of these products by plastic surgeons and dermatologists for various aesthetic procedures such as facelifts & face-limb reconstruction. Facial injections are also used for reducing wrinkles caused due to expression lines or permanent frowns.
The others application segment includes events/conferences/festivals and social occasions where participants can access beauty treatments at affordable prices without going to a hospital or medical center.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players coupled with high demand for minimally invasive procedures is expected to drive growth over the forecast period. In addition, increasing R&D activities and technological advancements are also anticipated to fuel regional growth during the same period.
Asia Pacific is expected to witness lucrative CAGR over the forecast years owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as China, India, Thailand, Malaysia & Singapore. Furthermore, growing awareness regarding various aesthetic treatments among people from developed economies is further anticipated boost regional demand during the forecast period.
Growth Factors:
- Increasing demand for minimally invasive procedures: The global facial injectable market is witnessing a shift towards minimally invasive procedures, which offer several benefits such as shorter recovery time and less pain. This is driving the demand for facial injectables.
- Growing popularity of non-surgical treatments: A growing number of people are opting for non-surgical treatments such as facial injectables to achieve a youthful appearance without going under the knife. This is fuelling the growth of the global facial injectable market.
- Rising awareness about aesthetic treatments: There has been a rise in awareness about aesthetic treatments in recent years, thanks to increasing media coverage and marketing by various players in the industry. This is helping to drive growth in the global facial injectable market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Facial Injectable Market Research Report
By Type
Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers, Particles
By Application
Hospitals, Clinics, Research, Others
By Companies
Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health, Galderma, Integra Lifesciences, Tei Biosciences, Fibrogen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Facial Injectable Market Report Segments:
The global Facial Injectable market is segmented on the basis of:
Types
Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers, Particles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bloomega BioTechnology
- Allergan
- Merz Pharma
- Bausch Health
- Galderma
- Integra Lifesciences
- Tei Biosciences
- Fibrogen
Highlights of The Facial Injectable Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hyaluronic Acid
- Collagen
- Botulinum Toxin
- Polymers
- Particles
- By Application:
- Hospitals
- Clinics
- Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Facial Injectable Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Facial injectables are a type of cosmetic treatment that use injections to fill in areas of the face that may be thin or have wrinkles. They can be used to improve the appearance of features such as the forehead, cheeks, chin, and neck.
Some of the key players operating in the facial injectable market are Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health, Galderma, Integra Lifesciences, Tei Biosciences, Fibrogen.
The facial injectable market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Facial Injectable Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Facial Injectable Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Facial Injectable Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Facial Injectable Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Facial Injectable Market Size & Forecast, 2018-2028 4.5.1 Facial Injectable Market Size and Y-o-Y Growth 4.5.2 Facial Injectable Market Absolute $ Opportunity
Chapter 5 Global Facial Injectable Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Facial Injectable Market Size Forecast by Type
5.2.1 Hyaluronic Acid
5.2.2 Collagen
5.2.3 Botulinum Toxin
5.2.4 Polymers
5.2.5 Particles
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Facial Injectable Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Facial Injectable Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Research
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Facial Injectable Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Facial Injectable Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Facial Injectable Analysis and Forecast
9.1 Introduction
9.2 North America Facial Injectable Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Facial Injectable Market Size Forecast by Type
9.6.1 Hyaluronic Acid
9.6.2 Collagen
9.6.3 Botulinum Toxin
9.6.4 Polymers
9.6.5 Particles
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Facial Injectable Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Research
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Facial Injectable Analysis and Forecast
10.1 Introduction
10.2 Europe Facial Injectable Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Facial Injectable Market Size Forecast by Type
10.6.1 Hyaluronic Acid
10.6.2 Collagen
10.6.3 Botulinum Toxin
10.6.4 Polymers
10.6.5 Particles
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Facial Injectable Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Research
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Facial Injectable Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Facial Injectable Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Facial Injectable Market Size Forecast by Type
11.6.1 Hyaluronic Acid
11.6.2 Collagen
11.6.3 Botulinum Toxin
11.6.4 Polymers
11.6.5 Particles
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Facial Injectable Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Research
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Facial Injectable Analysis and Forecast
12.1 Introduction
12.2 Latin America Facial Injectable Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Facial Injectable Market Size Forecast by Type
12.6.1 Hyaluronic Acid
12.6.2 Collagen
12.6.3 Botulinum Toxin
12.6.4 Polymers
12.6.5 Particles
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Facial Injectable Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Research
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Facial Injectable Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Type
13.6.1 Hyaluronic Acid
13.6.2 Collagen
13.6.3 Botulinum Toxin
13.6.4 Polymers
13.6.5 Particles
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Research
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Facial Injectable Market: Competitive Dashboard
14.2 Global Facial Injectable Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bloomega BioTechnology
14.3.2 Allergan
14.3.3 Merz Pharma
14.3.4 Bausch Health
14.3.5 Galderma
14.3.6 Integra Lifesciences
14.3.7 Tei Biosciences
14.3.8 Fibrogen